This is because ketone body defects inhibit lipid oxidation by inhibiting -hydroxybutyrylation, which prevents the metabolic flow from acetyl-coenzyme A delivery to the ketone bodies (72), thereby echoing the previously discussed inhibition of cardiac proliferation and regeneration by fatty acid metabolism
The tirzepatide muscle pain side effects resource covers what to watch for and when to be concerned
In the SURMOUNT-1 trial (Jastreboff et al., NEJM 2022), mean weight loss at 72 weeks varied by dose: 15.0% at 5 mg, 19.5% at 10 mg, and 22.5% at 15 mg
doi: 10.1007/s13318-022-00767-4 50 XuNLuoHLiMWuJWuXChenLet al
1v,w and Extended Data Fig
Free, no account required